## **Core Concept**
The question tests knowledge of specific side effects associated with anticancer drugs, particularly focusing on pulmonary toxicity manifesting as lung fibrosis. Several chemotherapeutic agents are known to cause pulmonary toxicity, which can range from pneumonitis to fibrosis.

## **Why the Correct Answer is Right**
Bleomycin is a well-documented chemotherapeutic agent known to cause pulmonary toxicity, which can progress to lung fibrosis. This side effect is dose-dependent and limits the cumulative dose that can be administered. The mechanism involves the generation of reactive oxygen species leading to damage of lung tissue.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Methotrexate can cause pulmonary toxicity but it more commonly presents as pneumonitis rather than fibrosis.
- **Option B:** Cisplatin is associated with nephrotoxicity, ototoxicity, and neurotoxicity but not commonly with lung fibrosis directly.
- **Option D:** Cyclophosphamide can cause pulmonary toxicity but it is less commonly associated with fibrosis compared to bleomycin.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the pulmonary toxicity of bleomycin is dose-dependent, and monitoring lung function tests is crucial during its administration.

## **Correct Answer:** . Bleomycin